TARCIC NORA has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are FLX BIO INC, AXOVANT SCIENCES GMBH and BORYUNG PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 18 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Tarcic Nora | 18 |
#2 | Haviv Asi | 10 |
#3 | Blaugrund Eran | 10 |
#4 | Kaye Joel | 10 |
#5 | Bar-Zohar Dan | 7 |
#6 | Kofler Dina | 6 |
#7 | Hayardeny Liat | 2 |
#8 | Knappertz Volker | 2 |
#9 | Gorfine Tali | 2 |
#10 | Sorani Ella | 2 |
Publication | Filing date | Title |
---|---|---|
US2012142730A1 | Use of laquinimod for reducing fatigue, improving functional status, and improving quality of life in multiple sclerosis patients |